IRDOpus Genetics, Inc.

$346M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$100,000

Gross Profit

$100,000100.0% margin

Operating Income

-$7M-7137.0% margin

Net Income

-$7M-7136.0% margin

EPS (Diluted)

$-0.52

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$463,000

Balance Sheet

Total Assets

$25M

Total Liabilities

$3M

Stockholders' Equity

$23M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$100,000	$0	—
Gross Profit	$100,000	$0	—
Operating Income	-$7M	-$1M	-465.5%
Net Income	-$7M	-$2M	-344.9%

IRD Q2 2021 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena